SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-22-000123
Filing Date
2022-11-17
Accepted
2022-11-17 16:18:58
Documents
15
Period of Report
2022-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20221115.htm   iXBRL 8-K 40691
2 EX-99.1 a2022_prx1117xnewdirectorc.htm EX-99.1 13744
7 SUMMIT LOGO image_0.jpg GRAPHIC 15680
  Complete submission text file 0001599298-22-000123.txt   248331

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20221115.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20221115_def.xml EX-101.DEF 14830
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20221115_lab.xml EX-101.LAB 28736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20221115_pre.xml EX-101.PRE 15427
9 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20221115_htm.xml XML 11114
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 221398597
SIC: 2834 Pharmaceutical Preparations